CCL4 was upregulated in both people with T1D and T2D [56], and its inhibition had a protective effect on pancreatic beta-cells, increased insulin sensitivity, and delayed the progression of hyperglycaemia, suggesting the critical role of CCL4-related inflammation in the progression of diabetes [57]. This evidence concerns the gene INS and diabetes mellitus.